Carolyn Kong

Dr. Kong is Chief Business & Medical Officer at IBSA Pharma Inc. Prior to IBSA, Dr. Kong held several senior management roles covering new business development, commercial strategy and global marketing at Fidia Pharma, Endo Pharmaceuticals and Johnson & Johnson. She also worked at GD Searle/Pharmacia in new product planning, and Bristol- Myers Squibb in the cardiovascular franchise. Dr. Kong received her B.S. in Pharmacy from Rutgers University and Pharm.D. from the State University of New York at Buffalo.